SRTA Strata Critical Medical Inc.

  1. Stocks
  2. Industrials
  3. NASDAQ: SRTA

Price (delayed)

$5.02

Market cap

$434.36M

P/E Ratio

8.96

Dividend/share

N/A

EPS

$0.56

Enterprise value

$379.84M

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 42
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 67
Highlights
The gross profit has soared by 53% YoY and by 34% QoQ
The revenue has grown by 44% year-on-year and by 29% since the previous quarter
The debt has dropped by 51% year-on-year but it is up by 35% since the previous quarter
The quick ratio has decreased by 28% YoY and by 8% QoQ
Sector: Industrials
Industry: Airports & Air Services
Website: https://www.blade.com
Peers: PINS

Key stats

What are the main financial stats of SRTA

SRTA stock price

How has the Strata Critical Medical stock price performed over time
Intraday
-1.38%
1 week
-0.4%
1 month
-4.74%
1 year
N/A
YTD
4.37%
QTD
-4.74%

Financial performance

How have Strata Critical Medical's revenue and profit performed over time
Revenue
$254.27M
Gross profit
$55.14M
Operating income
-$19.96M
Net income
$46.99M
Gross margin
21.7%
Net margin
18.5%
Strata Critical Medical's operating margin has surged by 55% YoY and by 31% QoQ
The gross profit has soared by 53% YoY and by 34% QoQ
The revenue has grown by 44% year-on-year and by 29% since the previous quarter
SRTA's operating income is up by 35% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does SRTA's price correlate with its fundamentals

Growth

What is Strata Critical Medical's growth rate over time

Valuation

What is Strata Critical Medical stock price valuation
P/E
8.96
P/B
1.53
P/S
1.68
EV/EBIT
8.08
EV/EBITDA
6.72
EV/Sales
1.49
Strata Critical Medical's EPS has increased by 12% QoQ
The equity has increased by 30% year-on-year and by 2.4% since the previous quarter
SRTA's P/B is 18% higher than its 5-year quarterly average of 1.3 and 9% higher than its last 4 quarters average of 1.4
The revenue has grown by 44% year-on-year and by 29% since the previous quarter
The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 2.7 and 12% less than its last 4 quarters average of 1.9

Efficiency

How efficient is Strata Critical Medical business performance
The ROIC is up by 20% since the previous quarter
Strata Critical Medical's return on sales has decreased by 12% QoQ
The company's return on equity rose by 7% QoQ
The ROA has increased by 7% QoQ

Dividends

What is SRTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SRTA.

Financial health

How did Strata Critical Medical financials performed over time
Strata Critical Medical's total liabilities has increased by 36% YoY but it has decreased by 10% QoQ
The total assets is up by 31% year-on-year
The debt is 98% smaller than the equity
Strata Critical Medical's debt to equity has soared by 100% from the previous quarter but it has plunged by 50% YoY
The debt has dropped by 51% year-on-year but it is up by 35% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.